that's right. as long as we remain on this low bu

that's right. as long as we remain on this low budget OTC, and as long as we remain pre-revenue, we're at the mercy of the traders. i don't blame them - that's just what they do.

so, we can't control or sway them - rather, it's our job to get an approval - to get (significant revenue) - and to get the resulting uplist. at that point, we'll be available to big investors - including wealthy individuals and institutions that won't be looking to trade in and out for a few cents. they'll put 10s of millions (or more) to work in a fell swoop - and will hammer any of these jackleg traders trying to knock the stock down with $10,000. can't wait to see that.

but until we get an approval and / or meaningful revenue (hopefully both) we will continue to sway in the "OTC breeze". and i've said it half a dozen times - i'll never return to the OTC swamp after this investment....